CTL019 (tisagenlecleucel): CAR-T therapy for relapsed and refractory B-cell acute lymphoblastic leukemia
Stephanie Vairy,* Julia Lopes Garcia,* Pierre Teira, Henrique Bittencourt Division of Haematology and Oncology, Department of Pediatrics, CHU Sainte-Justine, Université de Montréal, Montréal, QC, Canada *These authors contributed equally to this work Abstract: Ove...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2018-11-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/ctl019-tisagenlecleucel-car-t-therapy-for-relapsed-and-refractory-b-ce-peer-reviewed-article-DDDT |